Newport Medical Solutions India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.60 M
as on 16-11-2024
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 16-11-2024
- Revenue 24.28%
(FY 2023)
- Profit 2.58%
(FY 2023)
- Ebitda 25.85%
(FY 2023)
- Net Worth 23.91%
(FY 2023)
- Total Assets 19.84%
(FY 2023)
About Newport Medical Solutions India
The Corporate was formerly known as Omnimed Solutions Private Limited. The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹2.00 M.
Vijaya Yerneni and Sudheer Yerneni serve as directors at the Company.
- CIN/LLPIN
U72300TG2016PTC103648
- Company No.
103648
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Newport Medical Solutions India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijaya Yerneni  | Director | 27-Nov-2018 | Current |
| Sudheer Yerneni | Director | 13-Jun-2023 | Current |
Financial Performance of Newport Medical Solutions India.
Newport Medical Solutions India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.28% increase. The company also saw a slight improvement in profitability, with a 2.58% increase in profit. The company's net worth Soared by an impressive increase of 23.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Newport Medical Solutions India?
In 2023, Newport Medical Solutions India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 24 May 2022 | ₹2.00 M | Open |
How Many Employees Work at Newport Medical Solutions India?
Newport Medical Solutions India has a workforce of 186 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Newport Medical Solutions India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Newport Medical Solutions India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
